Richard Weaver

"Don't think that just because you've done a Biology or Chemistry degree, this is your path forever....I didn't become an entrepreneur until the age of 42. Your [career] path isn't fixed." Richard Weaver is a consultant to Biotech companies on their drug development programmes, specialising in DMPK. Before becoming a consultant, Rich was the founder of XenoGesis, a CRO he successfully sold to Sygnature Discovery in 2020. Rich talked to us about his career as a scientist and an entrepreneur, his formula for building a CRO and the advantages of organic growth. Enjoy!